In November 2024, Maze closed an oversubscribed $115 million Series D financing co-led by Frazier Life Sciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos ...
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...
THURSDAY, March 20, 2025 (HealthDay News) -- The Trump administration is weighing elimination of the U.S. Centers for Disease ...
Graphic design students at University of Wisconsin-Stout collaborate with Epic Systems to improve patient and healthcare ...
The Nation’s Report Card found in January that one-third of eighth graders failed to reach the National Assessment of ...
Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...
The federal Food and Drug Administration raided a major seller of poppers last week, and other brands have shut down their ...
Experts call for an EU-wide, mandatory Nutri-Score label to promote healthier diets and curb industry influence on policymaking. The paper highlights how corporate lobbying has delayed EU action on ...
The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for ...
UNICEF has warned that at least 14 million children worldwide are suffering from malnutrition and facing further disruption ...